纳米病毒发展了NV-387,这是一种针对多种病毒的广谱抗病毒,旨在获得快速批准。 NanoViricides develops NV-387, a broad-spectrum antiviral targeting multiple viruses, aiming for rapid approval.

纳米病毒公司正在研制NV-387,这是一种广泛频谱抗病毒药物,对包括流感、冠状病毒、RSV、MPox和麻疹在内的多种病毒有效。 NanoViricides Inc. is developing NV-387, a broad-spectrum antiviral drug effective against multiple viruses including influenza, coronaviruses, RSV, MPox, and measles. 该药物可以成为防备大流行病的重要工具。 The drug could become a key tool in pandemic preparedness. 该公司计划对MPox进行第二阶段试验,目的是取得孤儿药物地位、快速指定和各种迹象的优先审查凭单,有可能加快批准速度并提供经济利益。 The company plans a Phase II trial for MPox and aims for orphan drug status, fast-track designation, and priority review vouchers for various indications, potentially speeding up approval and providing economic benefits.